The Use of EDXRF for Pharmaceutical Material Elemental Analysis
White Paper Apr 24, 2018
The recent changes to the United States Pharmacopeia (USP) regarding requirements for elemental impurity testing has peaked interest into new ways to perform this testing. Combining these new requirements with the introduction of USP chapter <735> X-ray fluorescence spectrometry1 permits a new alternate method for quantifying elemental impurities in pharmaceutical materials.
This study demonstrates that the X-ray Fluorescence (XRF) spectrometry is capable of performing elemental analysis of a wide range of pharmaceutical (liquid, powder and solid) materials with high sensitivity, precision and accuracy for many of the elements required by the United States and the European pharmacopeias. Simple sample preparation, non-destructive analysis, no chemical waste, low running costs with a wide dynamic concentration range and good to excellent detection limits are some of the advantages of this technique.
Related White Papers
Download this whitepaper to learn why high data quality and integrity is critical to ensure patient safety and drug efficacy from research and development through to manufacturing.
READ MOREDownload the white paper “ New Advances in Multi-omics for Single-Cell Immune Profiling,” and learn about current protein profiling methods in immunology and advances in high-parameter quantification of protein biomarkers.
READ MOREWith the global proliferation and rapid adoption of cloud computing, laboratories are increasingly looking to take advantage of the benefits of the cloud, especially smaller companies where IT expertise is often lacking.
READ MORELike what you just read? You can find similar content on the communities below.
Biopharma Cell Science Drug DiscoveryTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
